“Cronos continues to make progress toward its goal of commercialization by September 2021, as evidenced by recently filed patents. Ultimately, we think Gingko and U.S. legislative changes offer more exciting opportunity than selling dried flower in Canada.
As for the small LP's, Aleafia is the one to look at.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.